SPY328.29-9.93 -2.94%
DIA266.47-8.19 -2.98%
IXIC11,083.29-348.06 -3.04%

Goldman Sachs Initiates Coverage On Athira Pharma with Buy Rating, Announces Price Target of $53

Goldman Sachs initiates coverage on Athira Pharma (NASDAQ:ATHA) with a Buy rating and announces Price Target of $53.

· 10/13/2020 04:59
Goldman Sachs initiates coverage on Athira Pharma (NASDAQ:ATHA) with a Buy rating and announces Price Target of $53.